- Home
- STNG vs LGND Comparison
STNG vs LGND Comparison
Compare STNG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STNG | LGND |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2010 | 1997 |
Fundamental Metrics
Financial Performance| Metric | STNG | LGND |
|---|---|---|
| Price | $82.33 | $298.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $83.33 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 766.6K | 157.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 2886.36 |
| EPS | N/A | ★ 1.63 |
| Revenue | N/A | ★ $141,102,000.00 |
| Revenue This Year | $4.31 | $1.25 |
| Revenue Next Year | N/A | $19.41 |
| P/E Ratio | ★ $10.06 | $177.96 |
| Revenue Growth | N/A | ★ 29.48 |
| 52 Week Low | $48.93 | $163.45 |
| 52 Week High | $90.06 | $326.63 |
Technical Indicators
Market Signals| Indicator | STNG | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 53.25 |
| Support Level | $73.42 | $286.99 |
| Resistance Level | $87.39 | $294.00 |
| Average True Range (ATR) | 2.65 | 7.78 |
| MACD | 0.09 | 0.78 |
| Stochastic Oscillator | 35.90 | 79.25 |
Price Performance
Historical ComparisonAbout STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.